Is treat-to-target really working in rheumatoid arthritis? a longitudinal analysis of a cohort of patients treated in daily practice (RA BIODAM).
Josef S SmolenRobert Bm LandewéDésirée Mfm van der HeijdeAlexandre SeprianoOliver FitzGeraldMikkel OstergaardJoanne HomikOri ElkayamJ Carter ThorneMargaret LarcheGianfranco FerraccioliMarina BackhausGilles BoireBernard CombeThierry SchaeverbekeAlain SarauxMaxime DougadosMaurizio RossiniMarcello GovoniLuigi SinigagliaAlain G CantagrelCornelia F AllaartCheryl BarnabeClifton O BinghamPaul P TakDirkjan van SchaardenburgHilde Berner HammerRana DadashovaEdna HutchingsJoel PaschkeWalter P MaksymowychPublished in: Annals of the rheumatic diseases (2020)
In daily clinical practice, the correct application of a T2T-strategy (especially sustained T2T) in patients with RA leads to higher rates of remission.